Impax's Appeal Too Late In Amrix Case, Fed. Circ. Says
The Federal Circuit has blocked Impax Laboratories Inc. from selling a generic version of Cephalon Inc.'s muscle relaxant Amrix, finding that Impax waited too long to appeal the sales ban put in...To view the full article, register now.
Already a subscriber? Click here to view full article